Last reviewed · How we verify
NCT05175079
Acupressure in Hyperemesis Gravidarum
NA trial testing Acupressure band in Hyperemesis Gravidarum in 90 participants. Completed in 31 August 2017.
31 August 2017
Quick facts
| Lead sponsor | Universiti Kebangsaan Malaysia Medical Centre |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 90 |
| Start date | 1 October 2016 |
| Primary completion | 31 August 2017 |
| Estimated completion | 31 August 2017 |
| Sites | 1 location across Malaysia |
Drugs / interventions tested
- Acupressure band
- Standard treatment hospital protocol
Conditions studied
- Hyperemesis Gravidarum — all drugs for Hyperemesis Gravidarum →
Sponsor
Universiti Kebangsaan Malaysia Medical Centre — full company profile →
Who can join
Adults 18 to 50, female only, with Hyperemesis Gravidarum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To examine the degree of nausea, vomiting between the acupressure and control group in women with hyperemesis gravidarum
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of Acupressure at P6 on Nausea and Vomiting in Women with Hyperemesis Gravidarum: A Randomized Controlled Trial.
Mohd Nafiah NA, Chieng WK, Zainuddin AA, Chew KT, et al · · 2022 · cited 8× · PMID 36078602 · DOI 10.3390/ijerph191710886
Verify or expand the search:
- PubMed search for NCT05175079
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperemesis Gravidarum
Currently open trials in the same condition.
- NCT06615843 — Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up · NA · recruiting
Other Universiti Kebangsaan Malaysia Medical Centre trials
Trials by the same sponsor.
- NCT07466485 — The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFL · Phase 2 · recruiting
- NCT07041814 — A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRI · Phase 2 · not yet recruiting
- NCT07000227 — Mechanism of FODMAP Restriction on FGID Patients · NA · recruiting
- NCT05694858 — Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adu · Phase 1, PHASE2 · recruiting
- NCT07447310 — Comparing 360-degree VR Video of Local vs Overseas Environment on Psychological Health · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05175079 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universiti Kebangsaan Malaysia Medical Centre
- Last refreshed: 3 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05175079.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing